| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.0003 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.19 | 0.0006 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |